首页> 外文期刊>Current medical research and opinion >Real-world glycemic, blood pressure, and weight control in patients with type 2 diabetes mellitus treated with canagliflozin-an electronic health-record-based study
【24h】

Real-world glycemic, blood pressure, and weight control in patients with type 2 diabetes mellitus treated with canagliflozin-an electronic health-record-based study

机译:Canagliflozin治疗的2型糖尿病患者的现实血糖,血压和体重控制-基于电子健康记录的研究

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Canagliflozin (CANA) has been shown to improve HbA1c, blood pressure (BP), and weight in patients with type 2 diabetes mellitus (T2DM) in clinical trials. This study describes HbA1c, BP, and weight in T2DM patients treated with CANA in a real-world setting.
机译:背景:Canagliflozin(CANA)在临床试验中已显示可改善2型糖尿病(T2DM)患者的HbA1c,血压(BP)和体重。这项研究描述了在现实环境中接受CANA治疗的T2DM患者的HbA1c,BP和体重。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号